Equities

Plenum AG

Plenum AG

Actions
  • Price (EUR)7.80
  • Today's Change0.000 / 0.00%
  • Shares traded9.00
  • 1 Year change+13.87%
  • Beta0.8162
Data delayed at least 15 minutes, as of Nov 14 2024 20:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Plenum AG is a Germany-based management consulting company with focus on operational excellence and sourcing, information technology (IT) management, digital transformation, regulative transformation and SAP and enterprise resource planning (ERP) architectures. The Company mainly provides consulting services to businesses from the energy, credit intermediation and insurance industries.

  • Revenue in EUR (TTM)30.10m
  • Net income in EUR653.04k
  • Incorporated2013
  • Employees144.00
  • Location
    Plenum AGThe Squaire West 15, Am FlughafenFRANKFURT AM MAIN 60549GermanyDEU
  • Phone+49 6 964355240
  • Fax+49 69 643552460
  • Websitehttps://www.plenum.de/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Readcrest Capital AG0.00-141.44k3.05m0.00---------0.0444-0.04440.000.000.00-------63.16-53.49---101.69-----------124.170.00------12.09------
Deutsche Payment A1M SE481.09k-267.71k4.90m3.00--5.6271.8410.19-0.1529-0.15290.27480.49860.3208--2.37120,272.50-17.85---17.85-------55.65-----18.270.00---34.41--52.16------
sdm SE-100.00bn-100.00bn6.01m----0.871----------1.81----------------------------0.00--29.10--152.43------
Schulte-Schlagbaum AG-100.00bn-100.00bn12.43m378.00--------------------------2.74--2.97--56.78--1.79---------8.843.23-232.44---13.55--
Plenum AG30.10m653.04k13.24m144.0020.272.285.650.43980.38470.384717.733.431.9659.665.28184,671.704.244.495.765.8083.0684.812.163.062.5621.520.237525.8819.4620.80-17.7436.03----
Libero football finance AG50.00k-166.22k16.80m7.00------336.00-0.0042-0.00420.00130.000.1908--0.3648---63.42-22.99-66.09-298.96100.00---332.44-12.57---97.361.00---65.97--99.04------
11 88 0 Solutions AG56.31m-1.62m21.77m483.00--6.736.800.3867-0.0733-0.07332.340.12332.69--10.23109,550.60-7.76-9.42-19.28-18.3741.4242.31-2.89-4.70---0.51260.3169--1.855.86-23.00---28.73--
Syzygy AG69.92m2.37m38.07m554.0015.940.88625.490.54450.17690.17695.223.180.8057--4.34118,711.402.90-0.07144.25-0.100220.2026.503.61-0.1204--8.190.3645--1.601.7461.13---10.56--
Deufol SE304.75m-3.70m44.69m2.33k--0.3531.640.1467-0.4311-0.431135.7714.451.096.748.73136,904.80-1.131.52-1.532.0962.9460.92-1.041.580.8060.84380.410330.378.262.090.676310.23-8.2710.76
Exasol AG36.81m-3.50m63.17m193.00--15.31--1.72-0.118-0.1181.300.15351.54--24.69190,709.90-14.61-50.76-15.31-55.7294.0294.44-9.51-71.5129.92--0.00--5.8914.6845.27---45.44--
BRAIN Biotech AG56.26m-8.77m64.45m309.00--3.94--1.15-0.4016-0.40162.580.74860.7834----170,487.90-12.31-10.71-15.45-14.4656.6656.16-15.71-17.47---2.340.00--11.7914.12-25.63--14.47--
Data as of Nov 14 2024. Currency figures normalised to Plenum AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.